Publication | Closed Access
Heparin-Associated Thrombocytopenia Treatment with Low Molecular Weight Heparin
76
Citations
0
References
1986
Year
ThrombopoiesisThrombosisVenous ThrombosisHepatologyBlood PlateletHeparin-associated Thrombocytopenia TreatmentClinical ImprovementHematologyPlatelet ConcentratesImmunologyPathologyHepatitisAntithrombotic ActivityCoagulopathyMedicineAnticoagulantHeparins
Eight patients with heparin associated thrombocytopenia (HAT) were treated by a low molecular weight heparin derivative (LMW). Biological and clinical improvement occurred in all patients. This efficiency confirms the antithrombotic activity of LMW and allows its use in patients with HAT.